Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FQ1JL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,327
Award facts
- Contract value 100% obligated
- $23,327.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $23,327 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors with an ultimate completion date of June 20, 2025. This firm fixed-price delivery order utilizes no set-aside designation and represents a competitively awarded contract for pharmaceutical medical supplies. The award is associated with AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor for military and veteran healthcare systems. The company maintains an extensive portfolio of federal contract awards predominantly with the Defense Logistics Agency, supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for Zepbound, a diabetes medication, exemplifies AmerisourceBergen's role in fulfilling federal medical supply needs through open competition and its capabilities to meet diverse pharmaceutical procurement requirements for the Department of Defense healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FQ1JL?
SPE2DB25FQ1JL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 18, 2025.
How much is contract SPE2DB25FQ1JL worth?
The government has obligated $23,327 on SPE2DB25FQ1JL.
Is contract SPE2DB25FQ1JL an order under another contract?
Yes. SPE2DB25FQ1JL is a delivery order under SPE2DB22D3011, an indefinite delivery contract.
Was contract SPE2DB25FQ1JL competed?
The extent of competition for SPE2DB25FQ1JL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award